4-(3-(4-(1H-1,2,4-triazol-1-yl)phenyl)-1-tosyl-4,5-dihydro-1H-pyrazol-5-yl)-N,N-dimethylaniline

ID: ALA4878303

PubChem CID: 164625831

Max Phase: Preclinical

Molecular Formula: C26H26N6O2S

Molecular Weight: 486.60

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)N2N=C(c3ccc(-n4cncn4)cc3)CC2c2ccc(N(C)C)cc2)cc1

Standard InChI:  InChI=1S/C26H26N6O2S/c1-19-4-14-24(15-5-19)35(33,34)32-26(21-8-10-22(11-9-21)30(2)3)16-25(29-32)20-6-12-23(13-7-20)31-18-27-17-28-31/h4-15,17-18,26H,16H2,1-3H3

Standard InChI Key:  OPKWFXKAJZNWEN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
   14.9034  -19.4186    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.6133  -19.0141    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   14.9081  -18.6016    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   15.8380  -20.4525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4984  -20.9339    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.1615  -20.4561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9098  -19.6760    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.0934  -19.6775    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.9355  -20.7109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.1019  -21.5121    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.8775  -21.7670    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4873  -21.2218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.3164  -20.4184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5410  -20.1672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.0614  -20.7023    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.4558  -20.1520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6785  -20.4017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.5056  -21.2012    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.1162  -21.7507    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.8912  -21.4981    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.7280  -21.4525    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.1216  -20.9048    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5569  -22.2516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.2641  -21.4756    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9471  -18.2697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.7575  -18.1890    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0914  -17.4454    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6134  -16.7831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7978  -16.8692    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4677  -17.6130    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.9468  -16.0370    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.5159  -22.2489    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3331  -22.2503    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   21.5869  -21.4735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.9265  -20.9922    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  5  6  1  0
  6  7  2  0
  7  8  1  0
  8  4  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14  9  1  0
  6  9  1  0
 15 16  2  0
 16 17  1  0
 17 18  2  0
 18 19  1  0
 19 20  2  0
 20 15  1  0
  4 15  1  0
 18 21  1  0
 21 22  1  0
 21 23  1  0
 12 24  1  0
  8  2  1  0
  2 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 28 31  1  0
 24 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4878303

    ---

Associated Targets(Human)

HCC1806 (544 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 486.60Molecular Weight (Monoisotopic): 486.1838AlogP: 4.18#Rotatable Bonds: 6
Polar Surface Area: 83.69Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.82CX LogP: 4.53CX LogD: 4.53
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.41Np Likeness Score: -1.89

References

1. Chen CH, Jiang Y, Wu R, Tang Y, Wan C, Gao H, Mao Z..  (2021)  Discovery of heterocyclic substituted dihydropyrazoles as potent anticancer agents.,  48  [PMID:34214509] [10.1016/j.bmcl.2021.128233]

Source